Stock listing
NASDAQ:MDCO The Medicines Company Stock
Follow The Medicines Company into a list and get an email when it puts out news.
Last close · NASDAQ:MDCO
$84.90 USD
Close on Jan 3, 2020 · No longer trades
- Lowest – highest close
- $5.09 – $84.96 USDSince Aug 8, 2000 · lowest Sep 27, 2001 · highest Jan 2, 2020
Delisted NASDAQ:MDCO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:MDCO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
The Medicines Company on 6ix
- Decks
- 6 decks · latest Mar 17, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Medicines — Technical Presentation (March 2017) | Technical | 17 slides | Mar 17, 2017 |
| Medicines — Technical Presentation (November 2016) | Technical | 14 slides | Nov 15, 2016 |
| Medicines — Investor Presentation (December 2015) | Investor deck | 35 slides | Dec 1, 2015 |
| Medicines — Investor Day (November 2014) | Investor day | 183 slides | Nov 5, 2014 |
| Medicines — Merger or Acquisition (December 2012) | Merger or acquisition | 35 slides | Dec 17, 2012 |
| Medicines — Investor Presentation (November 2010) | Investor deck | 29 slides | Nov 22, 2010 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Clive Meanwell Other companies: Metsera, Inc. (EXECUTIVE CHAIRMAN, Director · Since at least Jan 30, 2025); Fractyl Health, Inc. (Executive Chairman and Founder of Population Health Partners · Since at least Feb 1, 2024); Invivyd, Inc. (Director · Jun 22, 2022 – May 23, 2023 · Past); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); Population Health Investment Co Inc (Chief Executive Officer, Director · Nov 17, 2020 – Aug 24, 2021 · Past) | Chief Innovation Officer, Director · Jul 1, 2015 – Jan 6, 2020 · Past |
| Geno Germano Other companies: Harmony Biosciences Holdings, Inc. (Director · Since at least Apr 2, 2026); Entera Bio Ltd. (Chairman of the Board · Since at least Feb 4, 2026); Precision BioSciences, Inc. (Director · Since at least Mar 10, 2020); Sage Therapeutics Inc (Director · Since at least Jun 6, 2018); Bioverativ Inc (Director · Jan 31, 2018 – Mar 8, 2018 · Past) | Director · Nov 9, 2017 – Jan 6, 2020 · Past |
| Sarah J. Schlesinger Other companies: Armata Pharmaceuticals, Inc. (Director · Since at least Feb 12, 2020); Innoviva, Inc. (Board Member · Since at least Feb 12, 2018); Ariad Pharmaceuticals Inc (Director · Jul 15, 2013 – Feb 13, 2017 · Past) | Director · Feb 22, 2018 – Jan 6, 2020 · Past |
| Christopher Visioli Other companies: Metsera, Inc. (CHIEF FINANCIAL OFFICER · Since at least Jan 30, 2025); Population Health Investment Co Inc (Chief Financial Officer · Nov 17, 2020 – Nov 17, 2020 · Past) | Chief Financial Officer · Dec 27, 2019 – Jan 6, 2020 · Past |
| Melvin Spigelman Other companies: AN2 Therapeutics, Inc. (GATB · Since at least Mar 24, 2022); Synergy Pharmaceuticals Inc (Director · Aug 3, 2011 – Aug 15, 2018 · Past) | Director · May 25, 2006 – May 25, 2018 · Past |
| Brent Furse Other companies: Anthera Pharmaceuticals Inc (Director · Apr 27, 2016 – Jan 5, 2018 · Past) | EVP, Chief Customer Officer · Mar 3, 2014 – Aug 29, 2014 · Past |
| Mark Timney Other companies: Sarissa Capital Acquisition Corp (Director · Oct 20, 2020 – Oct 20, 2020 · Past) | Chief Executive Officer, Director · Dec 10, 2018 – Jan 6, 2020 · Past |
| Paris Panayiotopoulos Other companies: Corbus Pharmaceuticals Holdings, Inc. (Director · May 22, 2019 – May 22, 2019 · Past) | Director · May 30, 2019 – Jan 6, 2020 · Past |
| Armin M Kessler | Director · Mar 14, 2012 – May 10, 2018 · Past |
| Catharine S Newberry | Senior Vice President · Feb 14, 2006 – Jan 26, 2009 · Past |
All 12 people
| Person | Seat |
|---|---|
| Stephen M Rodin | EVP and General Counsel · Feb 17, 2015 – Jan 6, 2020 · Past |
| Victoria Kusiak | EVP, Chief Integrity Officer · Mar 3, 2014 – Mar 3, 2014 · Past |
Log in to ask 6ix AI your own questions about The Medicines Company.